KIT and metastatic malignant neoplasm in the lymph nodes: Concurrently, lymph node metastasis down-regulated gene sets associated with drug-responses, including cisplatin, a cancer chemotherapy drug and MP470, a novel c-Kit/AXL kinase inhibitor.